Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: The axtell regimen
C. F. Verschraegen, H. Arias-pulido, S. J. Lee, S. Movva, L. A. Cerilli, S. Eberhardt, B. Schmit, R. Quinn, C. Y. Muller, I. Rabinowitz, M. Purdy, D. Snyder, T. Bocklage
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: The axtell regimen'. Together they form a unique fingerprint.